Page last updated: 2024-08-21

quinazolines and Actinic Reticuloid Syndrome

quinazolines has been researched along with Actinic Reticuloid Syndrome in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (40.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benhuri, B; Chaudhari, SP; Ciccolini, KT; Duran, J; Kim, J; Lacouture, ME; Lucas, AS; Wu, S	1
Caro-Gutiérrez, D; Floristán Muruzábal, MU; Franco, AP; Gómez de la Fuente, E; López Estebaranz, JL	1
Chang, CH; Chang, JW; Hui, CY; Yang, CH	1
Arnault, JP; Baudin, E; Brassard, M; Giacchero, D; Maksimovic, L; Mateus, C; Ramacciotti, C; Robert, C; Schlumberger, M; Tomasic, G; Wechsler, J	1
Ishikawa, T; Kamide, R; Niimura, M	1
Chiba, M; Nagashima, M; Shiohara, T; Tanaka, Y	1
Hayakawa, K; Matsuo, I	1
Fujita, H; Matsuo, I	1
Kamide, R; Mochizuki, K; Sawada, S; Yamagishi, R	1
Ha, SH; Shao, BR; Zhan, CQ	1

Reviews

1 review(s) available for quinazolines and Actinic Reticuloid Syndrome

Article	Year
Incidence and risk of developing photosensitivity with targeted anticancer therapies. Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Clinical Trials as Topic; Humans; Incidence; Molecular Targeted Therapy; Neoplasms; Nivolumab; Photosensitivity Disorders; Piperidines; Quinazolines; Risk Assessment; Vemurafenib	2019

Article

Year

Incidence and risk of developing photosensitivity with targeted anticancer therapies.

Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:4

Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Clinical Trials as Topic; Humans; Incidence; Molecular Targeted Therapy; Neoplasms; Nivolumab; Photosensitivity Disorders; Piperidines; Quinazolines; Risk Assessment; Vemurafenib

2019

Trials

1 trial(s) available for quinazolines and Actinic Reticuloid Syndrome

Article	Year
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib. Archives of dermatology, 2012, Volume: 148, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Folliculitis; Hand-Foot Syndrome; Humans; Hyperpigmentation; Male; Middle Aged; Photosensitivity Disorders; Piperidines; Protein Kinase Inhibitors; Quinazolines; Thyroid Neoplasms	2012

Other Studies

8 other study(ies) available for quinazolines and Actinic Reticuloid Syndrome

Article	Year
Photo-induced erythema multiforme associated with vandetanib administration. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:4 Topics: Aged; Biopsy, Needle; Carcinoma, Medullary; Erythema Multiforme; Follow-Up Studies; Humans; Immunohistochemistry; Male; Neoplasm Staging; Photosensitivity Disorders; Piperidines; Quinazolines; Risk Assessment; Thyroid Neoplasms; Thyroidectomy	2014
Severe photosensitivity reaction to vandetanib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-20, Volume: 27, Issue:27 Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Photosensitivity Disorders; Piperidines; Protein Kinase Inhibitors; Quinazolines	2009
Photoleukomelanodermatitis (Kobori) induced by afloqualone. The Journal of dermatology, 1994, Volume: 21, Issue:6 Topics: Aged; Drug Eruptions; Humans; Male; Muscle Relaxants, Central; Photosensitivity Disorders; Pigmentation Disorders; Quinazolines	1994
Drug-induced, photosensitive, erythema multiforme-like eruption: possible role for cell adhesion molecules in a flare induced by Rhus dermatitis. Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:4 Topics: Adult; Antibodies, Monoclonal; Cell Adhesion Molecules; Dermatitis, Toxicodendron; Drug Eruptions; Erythema Multiforme; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Keratinocytes; Male; Photosensitivity Disorders; Quinazolines; Skin Tests	1990
Afloqualone phototoxicity--photosensitized lipid peroxidative potency and its biological significance. The Tokai journal of experimental and clinical medicine, 1989, Volume: 14, Issue:1 Topics: Hemolysis; Humans; In Vitro Techniques; Lipid Peroxidation; Muscle Relaxants, Central; Photosensitivity Disorders; Quinazolines; Ultraviolet Rays	1989
Phototoxic potential of afloqualone, a quinazolinone derivative, as determined by photosensitized inactivation of bacteriophage. Chemico-biological interactions, 1987, Volume: 64, Issue:1-2 Topics: Amino Acids; Bacteriophages; Hydroxides; Hydroxyl Radical; Muscle Relaxants, Central; Oxygen; Photosensitivity Disorders; Piperazines; Quinazolines	1987
[Two cases of photosensitive drug eruption induced by afloqualone]. Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1986, Volume: 96, Issue:12 Topics: Aged; Aged, 80 and over; Animals; Drug Eruptions; Guinea Pigs; Humans; Male; Middle Aged; Photosensitivity Disorders; Quinazolines; Skin	1986
[Evaluation of the phototoxicity of five antimalarial agents and praziquantel in mice]. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1986, Volume: 7, Issue:3 Topics: Animals; Antimalarials; Chloroquine; Female; Male; Mice; Naphthyridines; Photosensitivity Disorders; Praziquantel; Quinacrine; Quinazolines; Quinolines; Ultraviolet Rays	1986